#1 Clinical Trials Search in Europe
EU – Europe
AT – Austria
HR – Croatia
CZ – Czech Republic
DK – Denmark
EE – Estonia
FI – Finland
FR – France
DE – Germany
IS – Iceland
IT – Italy
LV – Latvia
LT – Lithuania
NL – Netherlands
NO – Norway
PL – Poland
PT – Portugal
RO – Romania
SK – Slovakia
SI – Slovenia
ES – Spain
SE – Sweden
  • Find a Clinical Trial

    Search Trials by Disease

    Non-small cell lung cancer Breast cancer Plasma cell myeloma Neoplasm Neoplasm malignant Acute myeloid leukaemia Colitis ulcerative Colorectal cancer metastatic Obesity Prostate cancer Crohn's disease Ovarian cancer Colorectal cancer Dementia Alzheimer's type Hepatocellular carcinoma Breast cancer metastatic Dermatitis atopic Malignant melanoma Non-small cell lung cancer metastatic Asthma More trials…
  • Rare Diseases Treatments

    Search Trials by Disease

    Ovarian epithelial cancer Neuroendocrine carcinoma Primitive neuroectodermal tumour Pulmonary arterial hypertension Thermal burn Obesity Astrocytoma malignant Thrombotic microangiopathy Osteopetrosis Mucous membrane pemphigoid Vaginal cancer Skin cancer Kaposi's sarcoma Usher's syndrome Osteomyelitis More trials…

    Learn about Rare Diseases

    Leukoencephalopathy – Basic Information Primary biliary cholangitis – Trials in Disease Ewing’s sarcoma recurrent – Treatment Systemic mastocytosis – Treatment Testicular leiomyosarcoma – Life with Disease Glomerulonephritis membranoproliferative – Life with Disease Lymphangioma – Basic Information Myelodysplastic syndrome with excess blasts – Diagnostics Mucopolysaccharidosis II – Diagnostics Mucopolysaccharidosis III – Basic Information More diseases…
  • Vaccine Clinical Trials
  • Pediatric Clinical Trials
  • Resources for Patients

    Browse Innovative Treatments

    PF-07868489 Lasmiditan Rigosertib Sodium FLUCLOXACILLIN SODIUM Darolutamide Mavorixafor Alkaline Phosphatase, Bovine Nitrofurantoin RO7268489 Ofatumumab Oritavancin Bupivacaine Hydrochloride Cyclophosphamide Monohydrate Protamine Sulfate Heparin Idarubicin 1,3-BUTYLENE GLYCOL VTX2735 SODIUM ALXN1920 GSKVX000000030918 More therapies…

    Learn about Your Condition

    Anogenital warts Corneal dystrophy Primary hyperoxaluria Ejection fraction normal Andersen-Tawil syndrome Colorectal cancer metastatic Hydrocele ROHHAD syndrome Uveal melanoma Postprandial hypoglycaemia Transient ischaemic attack Urethral stenosis Radicular pain Respiratory distress Onychomycosis More diseases…
  • Healthy Volunteers
  • Patient Guide
  • Our Partners
  • About Us
  • Contact us
  • Region
    🇪🇺 Europe
    🇦🇹 Austria
    🇭🇷 Croatia
    🇨🇿 Czech Republic
    🇩🇰 Denmark
    🇪🇪 Estonia
    🇫🇮 Finland
    🇫🇷 France
    🇩🇪 Germany
    🇮🇸 Iceland
    🇮🇹 Italy
    🇱🇻 Latvia
    🇱🇹 Lithuania
    🇳🇱 Netherlands
    🇳🇴 Norway
    🇵🇱 Poland
    🇵🇹 Portugal
    🇷🇴 Romania
    🇸🇰 Slovakia
    🇸🇮 Slovenia
    🇪🇸 Spain
    🇸🇪 Sweden

ABM

  • Study on Atezolizumab, Amivantamab, and Futibatinib for Patients with Advanced Solid Tumors

    Recruiting

    2 1 1 1
    Investigated diseases:
    • Neoplasm malignant
    Investigated drugs:
    • Futibatinib
    • Amivantamab
    • Atezolizumab
    France Germany Italy The Netherlands Spain Sweden

  • Study of rituximab and mycophenolate mofetil combination therapy compared to placebo for patients with interstitial lung disease related to systemic sclerosis

    Recruiting

    4 1 1
    Investigated diseases:
    • Systemic sclerosis pulmonary
    Investigated drugs:
    • Mycophenolate Mofetil
    • Rituximab
    France

  • Study on the Effects of Esketamine Hydrochloride and Propofol for Patients After Cardiac Arrest

    Recruiting

    3 1 1 1
    Investigated diseases:
    • Cardiac arrest
    Investigated drugs:
    • Esketamine Hydrochloride
    • Propofol
    Denmark

  • Study of individualized doses of botulinum toxin type A (incobotulinumtoxin) in adults with severe spasticity caused by brain damage

    Recruiting

    3 1 1 1
    Investigated diseases:
    • Muscle spasticity
    Investigated drugs:
    • Botulinum Toxin Type A
    • Clostridium Botulinum Neurotoxin Type A (150Kd), Free Of Complexing Proteins
    Spain

  • Study on Bortezomib and Temozolomide for Patients with Recurrent Grade IV Glioma

    Recruiting

    2 1 1 1
    Investigated diseases:
    • Malignant glioma
    Investigated drugs:
    • Bortezomib
    • Temozolomide
    Norway

  • Long-term Safety and Efficacy Study of Gene Therapy for Choroideremia and X-Linked Retinitis Pigmentosa Using AAV2-REP1 and AAV8-RPGR in Previously Treated Patients

    Recruiting

    3 1 1
    Investigated diseases:
    • Choroidal dystrophy
    • Retinitis pigmentosa
    Investigated drugs:
    • Timrepigene Emparvovec
    France Germany
Previous Page
1 … 387 388 389 390 391 … 1,610
Next Page

Investigational Drugs in This Location

See which drug candidates are part of clinical trials near you. Click for detailed trial information.

Medical Conditions Being Studied in This Location

Explore diseases currently included in clinical trials near you. Click to view trials and details for each condition.

European Clinical Trials Information Network

The European Clinical Trials Information Network is transforming access to clinical trial information for patients across Europe. By overcoming language barriers, our platform allows everyone, regardless of their native language, to easily find relevant and comprehensible clinical trial data. This innovative service connects patients to cutting-edge treatments, creating a unified European community where health and progress transcend borders.

This service is not affiliated with the European Commission, the EMA, or the official CTIS system. Most information comes from publicly available international clinical-trial registries, supplemented by data from academic centres, national regulators, and commercial sponsors. We aim to keep all content accurate and up to date.

Explore the full ecosystem of clinical research in Europe.

The information provided on this website is mainly derived from international public clinical trial databases (CTIS.eu). In addition, we are including supplementary sources, such as information provided by academic centers and national regulators, as well as information supplied by commercial sponsors (pharmaceutical companies and contract research organizations). We try to ensure that the information provided is accurate and up to date.

© 2026 CTIN Poland

Privacy Policy

Terms and Conditions

Contact

For Sites and Sponsors

Clinical Trial Locations

We use cookies

The website uses cookies to ensure the proper functioning of the site and to analyze internet traffic. Some cookies are essential for using the service and do not require consent. You can accept all cookies or use only the essential ones. Data is processed in accordance with our Privacy Policy. You have the right to withdraw your consent, access, rectify, delete, or limit the processing of your data at any time.
Numer nieprawidłowy!
Numer nieprawidłowy!